ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2089

High Local Cathepsin Activity in a Murine Rheumatoid Arthritis Model, but Not in an Osteoarthritis Model, Explains the Difference in Cartilage Vdipen Neoepitope Formation

Eline A. Vermeij1, Marije I. Koenders2, Onno J. Arntz3, Miranda B. Bennink1, Arjen B. Blom4, Peter L.E.M. van Lent5, Wim B. van den Berg1 and Fons A.J. van de Loo1, 1Rheumatology Research and Advanced Therapeutics, Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Rheumatology Research and Advanced Therapeutics, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands, 3Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 4Rheumatology Research & Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 5Rheumatology Research and Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Cathepsin, Fluorescence imaging, MMP and VDIPEN

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis: Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint inflammation and connective tissue destruction. On the other hand, osteoarthritis (OA) is regarded as a joint disease with cartilage destruction, but the role of inflammation in OA is still debatable. During joint inflammation and destruction, a variety of proteases are upregulated, including different cathepsins and matrix-metalloproteinases (MMPs). MMPs are a large group of enzymes known to degrade the extracellular matrix during both RA and OA, causing cartilage proteoglycan depletion and breakdown of the collagen network, leading to erosion. Cathepsins are lysosomal proteases which are abundantly found in the synovial fluid and the lining tissue of arthritic joints. In this study we investigated cathepsin and MMP activity in the process of cartilage destruction, in both a RA and an OA model.

Methods: Collagen-induced arthritis (CIA) was induced in DBA1/J mice, mimicking a RA model. Destabilization of the medial meniscus (DMM) was induced in C57Bl6/N mice causing instability of the joint and subsequently osteoarthritic features. For the CIA model at day 30 and for the DMM model at day 56, fluorescent imaging was performed using Sense 680 probes (PerkinElmer, Massachusetts, USA) and enzyme activity was detected using the IVIS Lumina (Caliper Life Sciences). The ProSense 680 probe becomes activated upon enzymatic cleavage by cathepsins, whereas the MMPSense 680 can be activated by different MMPs. After imaging, mice were sacrificed and knee and ankle joints were dissected and processed for histology. Sections were also immunostained for VDIPEN, a neoepitope of aggrecan cleaved by MMPs.

Results: The ProSense as well as the MMPSense showed a 3 times higher fluorescent signal intensity during CIA, indicating both cathepsin and MMP activity in this model. Interestingly, on the other hand, only MMP activity (1,5 times higher), but no cathepsins activity, could be measured in the DMM model. On histological level, although different in severity, the CIA model and the DMM model both showed features of cartilage damage. In the CIA model, more VDIPEN staining was seen with increasing severity of the disease; on the other hand, in the DMM model no VDIPEN staining was seen above baseline levels.

Conclusion: In the CIA model, inflammation and destruction are correlated, while the DMM model showed MMP activity without inflammation. Mort et al. (1998) showed that cathepsin-B can also cleave aggrecan, and can thereby form the VDIPEN neoepitope. Because no cathepsin activity could be measured in the DMM model, this can explain the absence of the VDIPEN neoepitope. This argues for a role of cathepsins in cartilage destruction but their role in CIA remains to be determined. Combining the imaging of local enzyme activity using activatable fluorescent probes together with cartilage neoepitope immunolocalization may unravel the processes involved in joint destruction.


Disclosure:

E. A. Vermeij,
None;

M. I. Koenders,
None;

O. J. Arntz,
None;

M. B. Bennink,
None;

A. B. Blom,
None;

P. L. E. M. van Lent,
None;

W. B. van den Berg,
None;

F. A. J. van de Loo,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-local-cathepsin-activity-in-a-murine-rheumatoid-arthritis-model-but-not-in-an-osteoarthritis-model-explains-the-difference-in-cartilage-vdipen-neoepitope-formation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology